Summary: In 2004, the average wholesale price of available MS disease-modifying therapies was $16,000. In 2013, the average price was $61,000; last year, the average price was more than $83,000. That's why my guest this week is David Mitchell, founder & president of Patients for Affordable Drugs. We're also talking about a new stem cell therapy study, a new way to avoid overheating when you exercise, and using telemedicine for managing MS. And we are incredibly excited about the new RealTalk MS Alexa skill!
